Yuan Xun, Yi Ming, Dong Bing, Chu Qian, Wu Kongming
Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, P.R. China.
Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China.
J Cancer. 2021 Jan 1;12(4):1240-1248. doi: 10.7150/jca.51179. eCollection 2021.
Keratin 19 (KRT19) is the intermediate filament that constitutes the cytoskeleton and regulates cell-cycle and cell death. We aimed to assess whether KRT19 was involved in lung cancer development. The expression of KRT19 in lung cancer was evaluated from mRNA expression on open databse and protein abundance on tumor tissue array. Using open microarray gene expression datasets and differential expression analysis, we found that KRT19 was upregulated in lung cancer compared with normal tissue. Further analysis suggested that KRT19 mRNA expression was correlated with tumor progression and overall survival in lung cancer patients. As KRT19 was overexpressed in adenocarcinoma (AC) and squamous cell carcinoma (SCC), we examined the prognostic value of KRT19 protein abundance by tissue microarray (TMA). The results suggested that protein expression of KRT19 was significantly associated with overall survival of SCC. Giving the prognostic role of KRT19 in lung cancer, KRT19 could be considered as an potential molecular marker in lung cancer, especially in SCC.
角蛋白19(KRT19)是构成细胞骨架并调节细胞周期和细胞死亡的中间丝。我们旨在评估KRT19是否参与肺癌的发生发展。通过公开数据库中的mRNA表达以及肿瘤组织芯片上的蛋白质丰度来评估KRT19在肺癌中的表达。利用公开的微阵列基因表达数据集和差异表达分析,我们发现与正常组织相比,KRT19在肺癌中上调。进一步分析表明,KRT19 mRNA表达与肺癌患者的肿瘤进展和总生存期相关。由于KRT19在腺癌(AC)和鳞状细胞癌(SCC)中过表达,我们通过组织芯片(TMA)检测了KRT19蛋白丰度的预后价值。结果表明,KRT19的蛋白表达与SCC的总生存期显著相关。鉴于KRT19在肺癌中的预后作用,KRT19可被视为肺癌尤其是SCC中的潜在分子标志物。